{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["1(2)"],"submitter":["Narang P"],"pubmed_abstract":["<h4>Purpose</h4>To evaluate the Advanced Vision Analyzer (AVA; Elisar Vision Technology) and to compare pointwise threshold sensitivity and functional correlation of Elisar Standard Algorithm (ESA) with the Swedish Interactive Threshold Algorithm (SITA) of the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Inc).<h4>Design</h4>Prospective, cross-sectional, observational case series.<h4>Participants</h4>One hundred sixty eyes (85 control participants, 75 glaucoma patients) for functional assessment, 15 eyes for test-retest variability (TRV), 107 eyes for blind spot trial (45 normal eyes, 62 glaucoma eyes) were recruited consecutively. A separate group of participants was chosen for each assessment.<h4>Methods</h4>All participants underwent ESA and SITA Standard 24-2 testing, and 1 eye of "],"journal":["Ophthalmology science"],"pagination":["100035"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9559955"],"repository":["biostudies-literature"],"pubmed_title":["Advanced Vision Analyzer-Virtual Reality Perimeter: Device Validation, Functional Correlation and Comparison with Humphrey Field Analyzer."],"pmcid":["PMC9559955"],"pubmed_authors":["Narang P","Agarwal A","Srinivasan M"],"additional_accession":[]},"is_claimable":false,"name":"Advanced Vision Analyzer-Virtual Reality Perimeter: Device Validation, Functional Correlation and Comparison with Humphrey Field Analyzer.","description":"<h4>Purpose</h4>To evaluate the Advanced Vision Analyzer (AVA; Elisar Vision Technology) and to compare pointwise threshold sensitivity and functional correlation of Elisar Standard Algorithm (ESA) with the Swedish Interactive Threshold Algorithm (SITA) of the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Inc).<h4>Design</h4>Prospective, cross-sectional, observational case series.<h4>Participants</h4>One hundred sixty eyes (85 control participants, 75 glaucoma patients) for functional assessment, 15 eyes for test-retest variability (TRV), 107 eyes for blind spot trial (45 normal eyes, 62 glaucoma eyes) were recruited consecutively. A separate group of participants was chosen for each assessment.<h4>Methods</h4>All participants underwent ESA and SITA Standard 24-2 testing, and 1 eye of ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jun","modification":"2025-04-04T23:01:50.549Z","creation":"2025-04-04T23:01:50.549Z"},"accession":"S-EPMC9559955","cross_references":{"pubmed":["36249304"],"doi":["10.1016/j.xops.2021.100035"]}}